Mark T. Iwicki
CHIEF EXECUTIVE OFFICER at KALA BIO Inc.
Sits on 3 boards. Last updated September 28, 2026
Time on boards
- Boards served
- 3
- Current seats
- 3
- Board service
- 10 years
- Director since
- 2023
10 years of board service in total across 3 boards, counting each seat separately. Longest: KALA BIO Inc., 3 years.
KALA BIO Inc.
Director · CHIEF EXECUTIVE OFFICER
Jade Biosciences Inc.
Director
Q32 Bio Inc.
Director
Chief executive roles
KALA BIO Inc.
· CHIEF EXECUTIVE OFFICER
Dates unknown
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Jun 26, 2024 | KALA BIO Inc. | Open-market sale | −15,168 | $4.75 | $72,048 |
| May 31, 2024 | KALA BIO Inc. | Open-market sale | −7,392 | $6.09 | $45,017 |
| Jan 4, 2024 | KALA BIO Inc. | Grant or award | +14,300 | — | — |
| Jan 4, 2024 | KALA BIO Inc. | Open-market sale | −4,539 | $6.73 | $30,547 |
| Jun 22, 2023 | KALA BIO Inc. | Grant or award | +158,873 | — | — |
| May 31, 2023 | KALA BIO Inc. | Grant or award | +71,715 | — | — |
| Jan 4, 2023 | KALA BIO Inc. | Grant or award | +41,700 | — | — |
| Jan 4, 2023 | KALA BIO Inc. | Open-market sale | −198 | $28.54 | $5,651 |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.